- Home
- ALXO vs CMU Comparison
ALXO vs CMU Comparison
Compare ALXO & CMU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- CMU
- Stock Information
- Founded
- ALXO 2015
- CMU 1987
- Country
- ALXO United States
- CMU United States
- Employees
- ALXO N/A
- CMU N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- CMU Investment Managers
- Sector
- ALXO Health Care
- CMU Finance
- Exchange
- ALXO Nasdaq
- CMU Nasdaq
- Market Cap
- ALXO 79.7M
- CMU 90.2M
- IPO Year
- ALXO 2020
- CMU N/A
- Fundamental
- Price
- ALXO $1.47
- CMU $3.50
- Analyst Decision
- ALXO Strong Buy
- CMU
- Analyst Count
- ALXO 6
- CMU 0
- Target Price
- ALXO $3.30
- CMU N/A
- AVG Volume (30 Days)
- ALXO 356.5K
- CMU 82.4K
- Earning Date
- ALXO 11-07-2025
- CMU 01-01-0001
- Dividend Yield
- ALXO N/A
- CMU 4.08%
- EPS Growth
- ALXO N/A
- CMU N/A
- EPS
- ALXO N/A
- CMU 0.07
- Revenue
- ALXO N/A
- CMU N/A
- Revenue This Year
- ALXO N/A
- CMU N/A
- Revenue Next Year
- ALXO N/A
- CMU N/A
- P/E Ratio
- ALXO N/A
- CMU $47.57
- Revenue Growth
- ALXO N/A
- CMU N/A
- 52 Week Low
- ALXO $0.40
- CMU $2.78
- 52 Week High
- ALXO $2.27
- CMU $3.38
- Technical
- Relative Strength Index (RSI)
- ALXO 49.39
- CMU 52.76
- Support Level
- ALXO $1.29
- CMU $3.48
- Resistance Level
- ALXO $1.56
- CMU $3.53
- Average True Range (ATR)
- ALXO 0.18
- CMU 0.02
- MACD
- ALXO 0.01
- CMU -0.00
- Stochastic Oscillator
- ALXO 65.90
- CMU 49.64
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About CMU MFS Municipal Income Trust
Mfs High Yield Municipal Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes. The company invest various top Healthcare companies, Airport, Universities (Secondary Schools), Universities (Dormitories), and many more, out of maximum revenue is gained from Healthcare Hospitals and Long Term Care.